Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |